Genome-wide determinants of mortality and motor progression in Parkinson’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Genome-wide determinants of mortality and motor progression in Parkinson’s disease ; volume:10 ; number:1 ; day:7 ; month:6 ; year:2024 ; pages:1-15 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (7.6.2024), 1-15, 12.2024

Creator: Tan, Manuela M. X.
Lawton, Michael A.
Pollard, Miriam I.
Brown, Emmeline
Real, Raquel
Carrasco, Alejandro Martinez
Bekadar, Samir
Jabbari, Edwin
Reynolds, Regina H.
Iwaki, Hirotaka
Blauwendraat, Cornelis
Kanavou, Sofia
Hubbard, Leon
Malek, Naveed
Grosset, Katherine A.
Bajaj, Nin
Barker, Roger A.
Burn, David J.
Bresner, Catherine
Foltynie, Thomas
Wood, Nicholas W.
Williams-Gray, Caroline H.
Andreassen, Ole A.
Toft, Mathias
Elbaz, Alexis
Artaud, Fanny
Brice, Alexis
Corvol, Jean-Christophe
Aasly, Jan
Farrer, Matthew J.
Nalls, Michael A.
Singleton, Andrew B.
Williams, Nigel M.
Ben-Shlomo, Yoav
Hardy, John
Hu, Michele T. M.
Grosset, Donald G.
Shoai, Maryam
Pihlstrøm, Lasse
Morris, Huw R.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41531-024-00729-8

URN: urn:nbn:de:101:1-2408151254009.369711650101

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tan, Manuela M. X.
Lawton, Michael A.
Pollard, Miriam I.
Brown, Emmeline
Real, Raquel
Carrasco, Alejandro Martinez
Bekadar, Samir
Jabbari, Edwin
Reynolds, Regina H.
Iwaki, Hirotaka
Blauwendraat, Cornelis
Kanavou, Sofia
Hubbard, Leon
Malek, Naveed
Grosset, Katherine A.
Bajaj, Nin
Barker, Roger A.
Burn, David J.
Bresner, Catherine
Foltynie, Thomas
Wood, Nicholas W.
Williams-Gray, Caroline H.
Andreassen, Ole A.
Toft, Mathias
Elbaz, Alexis
Artaud, Fanny
Brice, Alexis
Corvol, Jean-Christophe
Aasly, Jan
Farrer, Matthew J.
Nalls, Michael A.
Singleton, Andrew B.
Williams, Nigel M.
Ben-Shlomo, Yoav
Hardy, John
Hu, Michele T. M.
Grosset, Donald G.
Shoai, Maryam
Pihlstrøm, Lasse
Morris, Huw R.
SpringerLink (Online service)

Other Objects (12)

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Genome-wide determinants of mortality and motor progression in Parkinson’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework

Prevention of progression in Parkinson’s disease

Facial tremor in patients with Parkinson’s disease: prevalence, determinants and impacts on disease progression

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

Genetically-informed prediction of short-term Parkinson’s disease progression

Determinants of self-efficacy in patients with Parkinson’s disease

Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Evaluating a motor progression connectivity model across Parkinson’s disease stages

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Related objects

Reset password